Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention

NCT04097964 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1226

Last updated 2021-10-22

No results posted yet for this study

Summary

The study will utilize a stepped wedge cluster randomized design to examine the effectiveness of the full FaCES (Facilitating Change for Excellence in SBIRT) adolescent SBIRT change package. Primary care providers will be randomized as to when they receive training and begin delivery of FaCES with their 12 to 17 year old patients, which includes targeted feedback based on the patient's endorsed substance use level on the S2BI screening instrument.

Conditions

  • Adolescent Health Services
  • Adolescent Behavior

Interventions

BEHAVIORAL

brief intervention

1 minute or less of anticipatory guidance will be provided for adolescents reporting no use in the past year, a 3-5 minute abbreviated brief intervention including raising the subject, asking more questions, and correcting misinformation will be provided for adolescents reporting substance use once or twice in the past year, and a 5-10 minute full brief intervention will be provided, including the above steps as well as assessing readiness and negotiating change and scheduling a follow-up to potentially include a referral to treatment will be provided to adolescents reporting monthly to weekly use in the past year.

BEHAVIORAL

treatment as usual

standard care conducted by primary care providers during clinic visits

Sponsors & Collaborators

  • Conrad N. Hilton Foundation

    collaborator OTHER
  • Friends Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Shannon G Mitchell, PhD · Friends Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097964 on ClinicalTrials.gov